Fragment-based drug discovery using NMR spectroscopy

Baell JB (2010) Observations on screening-based research and some concerning trends in the literature. Future Med Chem 2:1529–1546 Baell JB, Holloway GA (2010) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53:2719–2740 Becattini B, Pellecchia M (2006) SAR by ILOEs: an NMR-based approach to reverse chemical genetics. Chemistry 12:2658–2662 Becattini B, Culmsee C, Leone M, Zhai D, Zhang X, Crowell KJ, Rega MF, Landshamer S, Reed JC, Plesnila N et al (2006) Structure-activity relationships by interligand NOE-based design and synthesis of antiapoptotic compounds targeting Bid. Proc Natl Acad Sci USA 103:12602–12606 Bohm HJ, Florh A, Stahl M (2004) Scaffold hopping. Drug Discov Today 1:217–224 Bollag G, Hirth P, Tsai J, Zhang J, Ibrahim PN, Cho H, Spevak W, Zhang C, Zhang Y, Habets G et al (2010) Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature 467:596–599 Borsi V, Calderone V, Fragai M, Luchinat C, Sarti N (2010) Entropic contribution to the linking coefficient in fragment based drug design: a case study. J Med Chem 53:4285–4289 Bottcher J, Jestel A, Kiefersauer R, Krapp S, Nagel S, Steinbacher S, Steuber H (2011) Key factors for successful generation of protein-fragment structures requirement on protein, crystals, and technology. Meth Enzymol 493:61–89 Campos-Olivas R (2011) NMR screening and hit validation in fragment based drug discovery. Curr Top Med Chem 11:43–67 Carr RA, Congreve M, Murray CW, Rees DC (2005) Fragment-based lead discovery: leads by design. Drug Discov Today 10:987–992 Chessari G, Woodhead AJ (2009) From fragment to clinical candidate–a historical perspective. Drug Discov Today 14:668–675 Chung S, Parker JB, Bianchet M, Amzel LM, Stivers JT (2009) Impact of linker strain and flexibility in the design of a fragment-based inhibitor. Nat Chem Biol 5:407–413 Cioffi M, Hunter CA, Packer MJ, Spitaleri A (2008) Determination of protein-ligand binding modes using complexation-induced changes in (1)h NMR chemical shift. J Med Chem 51:2512–2517 Congreve M, Carr R, Murray C, Jhoti H (2003) A ‘rule of three’ for fragment-based lead discovery? Drug Discov Today 8:876–877 Constantine KL, Davis ME, Metzler WJ, Mueller L, Claus BL (2006) Protein-ligand NOE matching: a high-throughput method for binding pose evaluation that does not require protein NMR resonance assignments. J Am Chem Soc 128:7252–7263 Dalvit C (2009) NMR methods in fragment screening: theory and a comparison with other biophysical techniques. Drug Discov Today 14:1051–1057 Dalvit C, Pevarello P, Tato M, Veronesi M, Vulpetti A, Sundstrom M (2000) Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water. J Biomol NMR 18:65–68 Dalvit C, Flocco M, Veronesi M, Stockman BJ (2002) Fluorine-NMR competition binding experiments for high-throughput screening of large compound mixtures. Comb Chem High Throughput Screen 5:605–611 Erlanson DA (2006) Fragment-based lead discovery: a chemical update. Curr Opin Biotechnol 17:643–652 Erlanson DA, Wells JA, Braisted AC (2004) Tethering: fragment-based drug discovery. Annu Rev Biophys Biomol Struct 33:199–223 Felli IC, Brutscher B (2009) Recent advances in solution NMR: fast methods and heteronuclear direct detection. Chem Phys Chem 10:1356–1368 Feng BY, Shelat A, Doman TN, Guy RK, Shoichet BK (2005) High-throughput assays for promiscuous inhibitors. Nat Chem Biol 1:146–148 Fernandez C, Jahnke W (2004) New approaches for NMR screening in drug discovery. Drg Discov Today 1:277–283 Fielding L (2007) NMR methods for the determination of protein-ligand dissociation constants. Prog NMR Spec 51:219–242 Friberg A, Vigil D, Zhao B, Daniels RN, Burke JP, Garcia-Barrantes PM, Camper D, Chauder BA, Lee T, Olejniczak ET et al (2013) Discovery of potent myeloid cell leukemia 1 (mcl-1) inhibitors using fragment-based methods and structure-based design. J Med Chem 56:15–30 Guntert P (2009) Automated structure determination from NMR spectra. Eur Biophys J 38:129–143 Hajduk PJ, Greer J (2007) A decade of fragment-based drug design: strategic advances and lessons learned. Nat Rev Drug Discov 6:211–219 Hajduk PJ, Meadows RP, Fesik SW (1997) Discovering high-affinity ligands for proteins. Science 278(497):499 Hajduk PJ, Augeri DJ, Mack J, Mendoza R, Yang J, Betz SF, Fesik SW (2000a) NMR-based screening of proteins containing 13C-labeled methyl groups. J Am Chem Soc 122:7898–7904 Hajduk PJ, Bures M, Praestgaard J, Fesik SW (2000b) Privileged molecules for protein binding identified from NMR-based screening. J Med Chem 43:3443–3447 Hajduk PJ, Mack JC, Olejniczak ET, Park C, Dandliker PJ, Beutel BA (2004) SOS-NMR: a saturation transfer NMR-based method for determining the structures of protein-ligand complexes. J Am Chem Soc 126:2390–2398 Hoffer L, Renaud JP, Horvath D (2011) Fragment-based drug design: computational & experimental state of the art. Comb Chem High Throughput Screen 14:500–520 Hopkins AL, Groom CR (2002) The druggable genome. Nat Rev Drug Discov 1:727–730 Hopkins AL, Groom CR, Alex A (2004) Ligand efficiency: a useful metric for lead selection. Drug Discov Today 9:430–431 Hung AW, Silvestre HL, Wen S, Ciulli A, Blundell TL, Abell C (2009) Application of fragment growing and fragment linking to the discovery of inhibitors of Mycobacterium tuberculosis pantothenate synthetase. Angew Chem Int Ed Engl 48:8452–8456 Huth JR, Mendoza R, Olejniczak ET, Johnson RW, Cothron DA, Liu Y, Lerner CG, Chen J, Hajduk PJ (2005) ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens. J Am Chem Soc 127:217–224 Ichihara O, Barker J, Law RJ, Whittaker M (2011) Compound design by fragment-linking. Mol Inf 30:298–306 Jahnke W (2002) Spin labels as a tool to identify and characterize protein-ligand interactions by NMR spectroscopy. Chem Bio Chem 3:167–173 Jahnke W, Florsheimer A, Blommers MJ, Paris CG, Heim J, Nalin CM, Perez LB (2003) Second-site NMR screening and linker design. Curr Top Med Chem 3:69–80 Jencks WP (1981) On the attribution and additivity of binding energies. Proc Natl Acad Sci USA 78:4046–4050 Jhoti H, Cleasby A, Verdonk M, Williams G (2007) Fragment-based screening using X-ray crystallography and NMR spectroscopy. Curr Opin Chem Biol 11:485–493 Klages J, Coles M, Kessler H (2007) NMR-based screening: a powerful tool in fragment-based drug discovery. Analyst 132:693–705 Kohlmann A, Zech SG, Li F, Zhou T, Squillace RM, Commodore L, Greenfield MT, Lu X, Miller DP, Huang WS et al (2013) Fragment growing and linking lead to novel nanomolar lactate dehydrogenase inhibitors. J Med Chem Krimm I (2012) INPHARMA-based identification of ligand binding site in fragment-based drug design. Med Chem Comm 3:605–610 Krishnamoorthy J, Yu VC, Mok YK (2010) Auto-FACE: an NMR based binding site mapping program for fast chemical exchange protein-ligand systems. PLoS One 5:e8943 Kuntz ID, Chen K, Sharp KA, Kollman PA (1999) The maximal affinity of ligands. Proc Natl Acad Sci USA 96:9997–10002 Leone M, Freeze HH, Chan CS, Pellecchia M (2006) The Nuclear Overhauser Effect in the lead identification process. Curr Drug Discov Technol 3:91–100 Lepre CA (2011) Practical aspects of NMR-based fragment screening. Meth Enzymol 493:219–239 Lescop E, Kern T, Brutscher B (2010) Guidelines for the use of band-selective radiofrequency pulses in hetero-nuclear NMR: example of longitudinal-relaxation-enhanced BEST-type 1H–15 N correlation experiments. J Magn Reson 203:190–198 Li D, DeRose EF, London RE (1999) The inter-ligand Overhauser effect: a powerful new NMR approach for mapping structural relationships of macromolecular ligands. J Biomol NMR 15:71–76 Ludwig C, Guenther UL (2009) Ligand based NMR methods for drug discovery. Front Biosci 14:4565–4574 Ludwig C, Michiels PJ, Wu X, Kavanagh KL, Pilka E, Jansson A, Oppermann U, Gunther UL (2008) SALMON: solvent accessibility, ligand binding, and mapping of ligand orientation by NMR spectroscopy. J Med Chem 51:1–3 Manzenrieder F, Frank AO, Kessler H (2008) Phosphorus NMR spectroscopy as a versatile tool for compound library screening. Angew Chem Int Ed Engl 47:2608–2611 Mayer M, Meyer B (1999) Characterization of ligand binding of saturation transfer difference NMR spectroscopy. Angew Chem Int Ed Engl 38:1784–1788 Mayer M, Meyer B (2001) Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J Am Chem Soc 123:6108–6117 McCoy MA, Wyss DF (2002) Spatial localization of ligand binding sites from electron current density surfaces calculated from NMR chemical shift perturbations. J Am Chem Soc 124:11758–11763 Meyer B, Peters T (2003) NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. Angew Chem Int Ed Engl 42:864–890 Murray CW, Blundell TL (2010) Structural biology in fragment-based drug design. Curr Opin Struct Biol 20:497–507 Pellecchia M, Bertini I, Cowburn D, Dalvit C, Giralt E, Jahnke W, James TL, Homans SW, Kessler H, Luchinat C et al (2008) Perspectives on NMR in drug discovery: a technique comes of age. Nat Rev Drug Discov 7:738–745 Pervushin K, Riek R, Wider G, Wuthrich K (1997) Attenuated T2 relaxation by mutual cancellation of dipole–dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc Natl Acad Sci USA 94:12366–12371 Rega MF, Wu B, Wei J, Zhang Z, Cellitti JF, Pellecchia M (2011) SAR by interligand nuclear overhauser effects (ILOEs) based discovery of acylsulfonamide compounds active against Bcl-x(L) and Mcl-1. J Med Chem 54:6000–6013 Reibarkh M, Malia TJ, Wagner G (2006) NMR distinction of single- and multiple-mode binding of small-molecule protein ligands. J Am Chem Soc 128:2160–2161 Sanchez-Pedregal VM, Reese M, Meiler J, Blommers MJ, Griesinger C, Carlomagno T (2005) The INPHARMA method: protein-mediated interligand NOEs for pharmacophore mapping. Angew Chem Int Ed Engl 44:4172–4175 Schanda P, Kupce E, Brutscher B (2005) SOFAST-HMQC experiments for recording two-dimensional heteronuclear correlation spectra of proteins within a few seconds. J Biomol NMR 33:199–211 Seidler J, McGovern SL, Doman TN, Shoichet BK (2003) Identification and prediction of promiscuous aggregating inhibitors among known drugs. J Med Chem 46:4477–4486 Shortridge MD, Powers R (2011) NMR Screening Methods for Drug Discovery. In: Biomolecular NMR Spectroscopy. IOS Press BV, Netherlands, p 381 Shuker SB, Hajduk PJ, Meadows RP, Fesik SW (1996) Discovering high-affinity ligands for proteins: SAR by NMR. Science 274:1531–1534 Sledz P, Silvestre HL, Hung AW, Ciulli A, Blundell TL, Abell C (2010) Optimization of the interligand Overhauser effect for fragment linking: application to inhibitor discovery against Mycobacterium tuberculosis pantothenate synthetase. J Am Chem Soc 132:4544–4545 Sun Q, Burke JP, Phan J, Burns MC, Olejniczak ET, Waterson AG, Lee T, Rossanese OW, Fesik SW (2012) Discovery of small molecules that bind to K-Ras and inhibit Sos-mediated activation. Angew Chem Int Ed Engl 51:6140–6143 Tengel T, Fex T, Emtenas H, Almqvist F, Sethson I, Kihlberg J (2004) Use of 19F NMR spectroscopy to screen chemical libraries for ligands that bind to proteins. Org Biomol Chem 2:725–731 Vanwetswinkel S, Heetebrij RJ, van Duynhoven J, Hollander JG, Filippov DV, Hajduk PJ, Siegal G (2005) TINS, target immobilized NMR screening: an efficient and sensitive method for ligand discovery. Chem Biol 12:207–216 Vazquez J, Tautz L, Ryan JJ, Vuori K, Mustelin T, Pellecchia M (2007) Development of molecular probes for second-site screening and design of protein tyrosine phosphatase inhibitors. J Med Chem 50:2137–2143 Vazquez J, De SK, Chen LH, Riel-Mehan M, Emdadi A, Cellitti J, Stebbins JL, Rega MF, Pellecchia M (2008) Development of paramagnetic probes for molecular recognition studies in protein kinases. J Med Chem 51:3460–3465 Warr WA (2011) Some trends in chem(o)informatics. Meth Mol Biol 672:1–37 Wu B, Zhang Z, Noberini R, Barile E, Giulianotti M, Pinilla C, Houghten RA, Pasquale EB, Pellecchia M (2013) HTS by NMR of combinatorial libraries: a fragment-based approach to ligand discovery. Chem Biol 20:19–33 Zhang X, Sanger A, Hemmig R, Jahnke W (2009) Ranking of high-affinity ligands by NMR spectroscopy. Angew Chem Int Ed Engl 48:6691–6694